Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Bemt, Lisette, van den Nieuwenhof, Lotte, Rutjes, Anne, van der Meer, Victor, Stege, Gerben, Wensing, Michel, Teichert, Martina, Schermer, Tjard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547069/
https://www.ncbi.nlm.nih.gov/pubmed/33037200
http://dx.doi.org/10.1038/s41533-020-00198-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547069/
https://www.ncbi.nlm.nih.gov/pubmed/33037200
http://dx.doi.org/10.1038/s41533-020-00198-5

Ejemplares similares